Literature DB >> 16157277

Fezl is required for the birth and specification of corticospinal motor neurons.

Bradley J Molyneaux1, Paola Arlotta, Tustomu Hirata, Masahiko Hibi, Jeffrey D Macklis.   

Abstract

The molecular mechanisms controlling the differentiation of neural progenitors into distinct subtypes of neurons during neocortical development are unknown. Here, we report that Fezl is required for the specification of corticospinal motor neurons and other subcerebral projection neurons, which are absent from Fezl null mutant neocortex. There is neither an increase in cell death in Fezl(-/-) cortex nor abnormalities in migration, indicating that the absence of subcerebral projection neurons is due to a failure in fate specification. In striking contrast, other neuronal populations in the same and other cortical layers are born normally. Overexpression of Fezl results in excess production of subcerebral projection neurons and arrested migration of these neurons in the germinal zone. These data indicate that Fezl plays a central role in the specification of corticospinal motor neurons and other subcerebral projection neurons, controlling early decisions regarding lineage-specific differentiation from neural progenitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157277     DOI: 10.1016/j.neuron.2005.08.030

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  216 in total

Review 1.  Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex.

Authors:  Kenneth Y Kwan; Nenad Sestan; E S Anton
Journal:  Development       Date:  2012-05       Impact factor: 6.868

Review 2.  Programming and reprogramming neuronal subtypes in the central nervous system.

Authors:  Caroline Rouaux; Salman Bhai; Paola Arlotta
Journal:  Dev Neurobiol       Date:  2012-07       Impact factor: 3.964

3.  Integration of H-2Z1, a somatosensory cortex-expressed transgene, interferes with the expression of the Satb1 and Tbc1d5 flanking genes and affects the differentiation of a subset of cortical interneurons.

Authors:  Nicolas Narboux-Nême; Rosette Goïame; Marie-Geneviève Mattéi; Michel Cohen-Tannoudji; Marion Wassef
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 4.  Annual Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders.

Authors:  John L R Rubenstein
Journal:  J Child Psychol Psychiatry       Date:  2010-08-24       Impact factor: 8.982

5.  Making glutamatergic neurons from GABAergic progenitors.

Authors:  Magdalena Götz
Journal:  Nat Neurosci       Date:  2010-11       Impact factor: 24.884

6.  A microfluidic device to investigate axon targeting by limited numbers of purified cortical projection neuron subtypes.

Authors:  Suzanne Tharin; Chandrasekhar R Kothapalli; Pembe Hande Ozdinler; Lincoln Pasquina; Seok Chung; Johanna Varner; Sarra DeValence; Roger Kamm; Jeffrey D Macklis
Journal:  Integr Biol (Camb)       Date:  2012-11       Impact factor: 2.192

7.  Ikaros promotes early-born neuronal fates in the cerebral cortex.

Authors:  Jessica M Alsiö; Basile Tarchini; Michel Cayouette; Frederick J Livesey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  Suppressor of Fused Is Critical for Maintenance of Neuronal Progenitor Identity during Corticogenesis.

Authors:  Odessa R Yabut; Gloria Fernandez; Trung Huynh; Keejung Yoon; Samuel J Pleasure
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

9.  Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury.

Authors:  Erik Mire; Nicole Thomasset; Lyn B Jakeman; Geneviève Rougon
Journal:  Mol Cell Neurosci       Date:  2007-10-03       Impact factor: 4.314

10.  Differential changes in the cellular composition of the developing marsupial brain.

Authors:  Adele M H Seelke; James C Dooley; Leah A Krubitzer
Journal:  J Comp Neurol       Date:  2013-08-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.